{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:59:28Z","timestamp":1792666768287,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:00:00Z","timestamp":1554768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002749","name":"Belgian Federal Science Policy Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002749","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jacc.2019.02.049","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T09:24:27Z","timestamp":1557307467000},"page":"2267-2282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":173,"title":["Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure"],"prefix":"10.1016","volume":"73","author":[{"given":"Chandan K.","family":"Nagaraju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouna","family":"Abdesselem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"Trenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eef","family":"Dries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Van Cleemput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Rega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Meyns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Llewelyn","family":"Roderick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald B.","family":"Driesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin R.","family":"Sipido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2019.02.049_bib1","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nrd.2016.89","article-title":"Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease","volume":"15","author":"Gourdie","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jacc.2019.02.049_bib2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jacc.2010.10.024","article-title":"Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction","volume":"57","author":"Kasner","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.02.049_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.109.931451","article-title":"Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction","volume":"4","author":"Westermann","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2019.02.049_bib4","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI74783","article-title":"Resident fibroblast lineages mediate pressure overload\u2013induced cardiac fibrosis","volume":"124","author":"Moore-Morris","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2019.02.049_bib5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","article-title":"Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities","volume":"90","author":"Russo","year":"2016","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2019.02.049_bib6","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1161\/hc5001.100833","article-title":"Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis","volume":"104","author":"Kawara","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.02.049_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yjmcc.2013.11.015","article-title":"Fibroblasts in myocardial infarction: a role in inflammation and repair","volume":"70","author":"Shinde","year":"2014","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2019.02.049_bib8","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.jacc.2015.03.520","article-title":"Interacting resident epicardium-derived fibroblasts and recruited bone marrow cells form myocardial infarction scar","volume":"65","author":"Ruiz-Villalba","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.02.049_bib9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCRESAHA.117.311490","article-title":"Infarct fibroblasts do not derive from bone marrow lineages","volume":"122","author":"Moore-Morris","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2019.02.049_bib10","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/CIRCRESAHA.116.305381","article-title":"Getting to the heart of the matter: new insights into cardiac fibrosis","volume":"116","author":"Leask","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2019.02.049_bib11","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac fibrosis: the fibroblast awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2019.02.049_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s10741-011-9266-y","article-title":"Tissue inhibitor of metalloproteinases (TIMPs) in heart failure","volume":"17","author":"Moore","year":"2012","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2019.02.049_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCRESAHA.112.266882","article-title":"Membrane-associated matrix proteolysis and heart failure","volume":"112","author":"Spinale","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2019.02.049_bib14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/cvr\/cvn315","article-title":"A\u00a0synthetic peptide from transforming growth factor-\u03b21 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats","volume":"81","author":"Hermida","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2019.02.049_bib15","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.ijcard.2012.11.067","article-title":"A\u00a0new anti-fibrotic drug attenuates cardiac remodeling and systolic dysfunction following experimental myocardial infarction","volume":"168","author":"Zhang","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2019.02.049_bib16","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jacc.2017.06.049","article-title":"Pharmacological and activated fibroblast targeting of G\u03b2\u03b3-GRK2 after myocardial ischemia attenuates heart failure progression","volume":"70","author":"Travers","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.02.049_bib17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1084\/jem.20171274","article-title":"Cardiac macrophages promote diastolic dysfunction","volume":"215","author":"Hulsmans","year":"2018","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jacc.2019.02.049_bib18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/01.CIR.104.3.286","article-title":"Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients","volume":"104","author":"L\u00f3pez","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.02.049_bib19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2019.02.049_bib20","first-page":"480","article-title":"Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy","volume":"1","author":"Shimada","year":"2013","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2019.02.049_bib21","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/heartjnl-2013-303927","article-title":"Assessment of valve haemodynamics, reverse ventricular remodelling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement: a cardiovascular magnetic resonance study","volume":"99","author":"Fairbairn","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2019.02.049_bib22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.CIR.98.7.656","article-title":"Regression of cellular hypertrophy after left ventricular assist device support","volume":"98","author":"Zafeiridis","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.02.049_bib23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.healun.2003.10.016","article-title":"Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support","volume":"24","author":"Rodrigue-Way","year":"2005","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2019.02.049_bib24","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.02.049_bib25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jacc.2017.05.040","article-title":"Cell-specific pathways supporting persistent fibrosis in heart failure","volume":"70","author":"Farris","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.02.049_bib26","doi-asserted-by":"crossref","first-page":"16850","DOI":"10.1073\/pnas.1316764110","article-title":"Activation of MRTF-A-dependent gene expression with a small molecule promotes myofibroblast differentiation and wound healing","volume":"110","author":"Velasquez","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2019.02.049_bib27","doi-asserted-by":"crossref","first-page":"13294","DOI":"10.1074\/jbc.M109.088864","article-title":"Interaction between periostin and BMP-1 promotes proteolytic activation of lysyl oxidase","volume":"285","author":"Maruhashi","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacc.2019.02.049_bib28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbadis.2016.11.006","article-title":"The role of \u03b1-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling","volume":"1863","author":"Shinde","year":"2017","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacc.2019.02.049_bib29","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nmeth.1220","article-title":"Lifeact: a versatile marker to visualize F-actin","volume":"5","author":"Riedl","year":"2008","journal-title":"Nat Methods"},{"key":"10.1016\/j.jacc.2019.02.049_bib30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-2828(08)80028-4","article-title":"The cellular basis of dilated cardiomyopathy in humans","volume":"27","author":"Beltrami","year":"1995","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2019.02.049_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijcard.2010.04.053","article-title":"Fibrosis in endstage human heart failure: severe changes in collagen metabolism and MMP\/TIMP profiles","volume":"151","author":"Polyakova","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2019.02.049_bib32","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/0002-8703(88)90763-6","article-title":"Inadequate collagen tethers in dilated cardiopathy","volume":"116","author":"Weber","year":"1988","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2019.02.049_bib33","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/CIRCRESAHA.116.309001","article-title":"Proliferation and recruitment contribute to myocardial macrophage expansion in chronic heart failure","volume":"119","author":"Sager","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2019.02.049_bib34","doi-asserted-by":"crossref","first-page":"e000773","DOI":"10.1161\/JAHA.113.000773","article-title":"Anti-remodeling and anti-fibrotic effects of the neuregulin-1\u03b2 glial growth factor 2 in a large animal model of heart failure","volume":"3","author":"Galindo","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2019.02.049_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacc.2006.02.055","article-title":"Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial","volume":"48","author":"Hudson","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.02.049_bib36","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.cardiores.2004.07.017","article-title":"Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction","volume":"64","author":"Ikeuchi","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2019.02.049_bib37","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00395-008-0739-7","article-title":"Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction","volume":"103","author":"Frantz","year":"2008","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacc.2019.02.049_bib38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/cvr\/cvt338","article-title":"Reversible and irreversible differentiation of cardiac fibroblasts","volume":"101","author":"Driesen","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2019.02.049_bib39","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/CS20130538","article-title":"microRNA-122 down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-\u03b21 up-regulation","volume":"126","author":"Beaumont","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jacc.2019.02.049_bib40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/cvr\/cvu184","article-title":"The microRNA-15 family inhibits the TGF\u03b2-pathway in the heart","volume":"104","author":"Tijsen","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2019.02.049_bib41","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/CIRCULATIONAHA.117.028145","article-title":"PAI-1 controls cardiomyocyte TGF-\u03b2 and cardiac fibrosis","volume":"136","author":"Flevaris","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.02.049_bib42","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1161\/CIRCRESAHA.116.308643","article-title":"Targeted ablation of periostin-expressing activated fibroblasts prevents adverse cardiac remodeling in mice","volume":"118","author":"Kaur","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2019.02.049_bib43","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.jacc.2016.01.030","article-title":"Matricellular protein CCN5 reverses established cardiac fibrosis","volume":"67","author":"Jeong","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.02.049_bib44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature24676","article-title":"IL-11 is a crucial determinant of cardiovascular fibrosis","volume":"552","author":"Schafer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2019.02.049_bib45","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCULATIONAHA.117.030742","article-title":"Single-cell sequencing of the healthy and diseased heart reveals cytoskeleton-associated protein 4 as a new modulator of fibroblasts activation","volume":"138","author":"Gladka","year":"2018","journal-title":"Circulation"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109719344304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109719344304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:22:10Z","timestamp":1760016130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109719344304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":45,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0735109719344304"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2019.02.049","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2019.02.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}